LA
UROV

LVW Advisors’s Urovant Sciences Ltd. UROV Stock Holding History

LVW Advisors’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39,451
Closed -$636K – 225
2020
Q4 		$636K Buy
39,451
+639
+2% +$7.92K 0.13% 100
2020
Q3 		$363K Hold
38,812
– – 0.08% 134
2020
Q2 		$382K Buy
38,812
+5,000
+15% +$48K 0.09% 110
2020
Q1 		$312K Sell
33,812
-5,500
-14% -$66.2K 0.08% 117
2019
Q4 		$610K Hold
39,312
– – 0.14% 91
2019
Q3 		$372K Buy
+39,312
New +$341K 0.09% 109

LVW Advisors's UROV Position: Q1 2021 in Review

LVW Advisors sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 39,451 shares — an estimated $636K sold.

LVW Advisors first reported a position in UROV in Q3 2019 and held it in 6 quarters. The position peaked at $636K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • LVW Advisors reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • LVW Advisors sold 39,451 Urovant Sciences Ltd. shares in Q1 2021, an estimated $636K.
  • LVW Advisors first reported a position in Urovant Sciences Ltd. in Q3 2019 and held it in 6 quarters.
  • LVW Advisors's Urovant Sciences Ltd. position peaked at $636K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on LVW Advisors's 13F filing for Q1 2021, filed 19 Apr 2021.